The US International Trade Commission has initiated an investigation into dental burs and kits brought into the US, with various Pakistani companies identified as respondents. The inquiry, conducted under Section 337 of the Tariff Act of 1930, follows a complaint by Huwais IP Holding LLC and Versah LLC, both Michigan-based entities. Allegations suggest that imported “osseodensification dental burs and kits thereof” violate two US patents and three registered US trademarks.
The complainants assert the existence of a domestic industry in the US, a prerequisite for trade actions under US law. The Commission, on January 13, authorized the probe to determine potential violations of US patent and trademark protections by the accused products imported, sold for importation, or sold within the US post-importation.
Numerous companies implicated in the case are situated in Pakistan, particularly in and around Sialkot, a renowned global hub for manufacturing surgical and dental instruments. Other respondents are located in the United Arab Emirates, the United Kingdom, Canada, Italy, Australia, and the US.
If the claims are substantiated, the complainants have urged the Commission to prohibit the import of the accused products into the US. They seek either a general exclusion order or a limited exclusion order targeting specific suppliers, along with cease-and-desist orders against the named respondents.
All respondents are required to submit formal responses to the amended complaint within 20 days of being served, as per the USITC. Failure to comply within the stipulated timeframe may result in a waiver of the right to challenge the allegations, potentially leading to the issuance of exclusion or cease-and-desist orders without further notification.
The Office of Unfair Import Investigations at the USITC is involved in the case, which pertains to Section 337 investigations focusing on unfair import trade practices, including intellectual property infringements. While the Commission does not provide monetary damages, it can prevent products from entering the US market.
For Pakistan, this case underscores the escalating risks for exporters supplying medical and dental goods to the US. Manufacturers in Sialkot heavily rely on access to Western healthcare markets, which could be disrupted swiftly by US trade measures if intellectual property violations are confirmed. The investigation contributes to the heightened scrutiny of foreign-made medical devices entering the US, reflecting increased enforcement of patent and trademark protections in the healthcare sector.
